Jie Li
Family · Flushing, NYNPI 1396340915
Payments from drug & device makers
Across 82 payments — averaging $35.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Esperion Therapeutics, Inc.$729
- Neurocrine Biosciences, Inc.$390
- Sun Pharmaceutical Industries Inc.$378
- Regeneron Healthcare Solutions, Inc.$324
- Arcutis Biotherapeutics, Inc.$254
- EPI Health, LLC$170
- plus $691 from 15 others
What the payments were for
- Food & beverage$2,85597%
- Education$803%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Esperion Therapeutics, Inc. | 5 | $729 |
| Neurocrine Biosciences, Inc. | 3 | $390 |
| Sun Pharmaceutical Industries Inc. | 15 | $378 |
| Regeneron Healthcare Solutions, Inc. | 8 | $324 |
| Arcutis Biotherapeutics, Inc. | 17 | $254 |
| EPI Health, LLC | 10 | $170 |
| Gilead | 1 | $125 |
| Incyte Corporation | 5 | $105 |
| Daiichi Sankyo Inc. | 1 | $80 |
| Madrigal Pharmaceuticals | 2 | $69 |
| Johnson & Johnson | 2 | $56 |
| LNHC, Inc | 2 | $49 |
| UCB, Inc. | 2 | $39 |
| E.r. Squibb & Sons, L.L.C. | 2 | $31 |
| Sanofi | 1 | $25 |
| Insmed, Inc. | 1 | $24 |
| Intercept Pharmaceuticals, Inc. | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $19 |
| IBSA Pharma Inc. | 1 | $19 |
| Almirall LLC | 1 | $15 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,935 in reported general payments places this provider in the 85th percentile of 8,883 family providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Epolamine | 14 | $8,513 |
| Atorvastatin Calcium | 62 | $383 |
| Donepezil Hcl | 29 | $273 |
| Losartan Potassium | 33 | $258 |
| Triamcinolone Acetonide | 17 | $227 |
| Amlodipine Besylate | 34 | $197 |
| Tamsulosin Hcl | 13 | $184 |
| Omeprazole | 26 | $164 |
| Alendronate Sodium | 24 | $146 |
| Esomeprazole Magnesium | 11 | $141 |
| Fluticasone Propionate | 12 | $122 |
| Metformin Hcl | 27 | $121 |
| Gabapentin | 14 | $110 |
| Chlorhexidine Gluconate | 16 | $75 |
| Zolpidem Tartrate | 11 | $70 |
Paid to pharmacies, not to this prescriber.
Other family in Flushing
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Suzanne WilsonIthaca$179K
- Jonathan LesuerSyracuse$172K
- Sheri HillNorth Syracuse$165K
- Cathrine CurtinBronxville$155K
- Mary Sullivan-WhalenNew York$137K
- Sarah AljahmiRockville Centre$87K
- John de OcaStaten Island$86K
- Fara StrickerGlen Oaks$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.